| Lesion SUVmax | P-value | |
---|---|---|---|
Mean ± SD | Median (IQR) | ||
Pathology | Â | Â | Â |
• IDC(n=36) | 3.96±3.1 | 2.85(3.33) | =0.258# |
• ILC(n=3) | 2.41±2.98 | 0.8 | |
• Other (n=1) | 1 |  | |
Menopausal State | Â | Â | Â |
• Pre- (n=19) | 14.55 ± 2.1 | 13 (6) | 0.003* |
• Post- (n=21) | 7.45 ± 1.0 | 7 (2) | |
Disease Stage | Â | Â | Â |
• I & II (n=27) | 8.79 ± 1.1 | 7 (2) | = 0.017* |
• III & IV (n=13) | 15.06 ± 2.9 | 14 (5) | |
ER-Receptors | Â | Â | Â |
Positive (n=31) | 9.12 ± 5.7 | 7 (6) | = 0.010** |
Negative (n=9) | 16.70 ± 9.6 | 12.5 (11) | |
PR-Receptors | Â | Â | Â |
Positive (n=24) | 9.13 ± 6.2 | 7 (5) | = 0.113** |
Negative (n=16) | 13.37 ± 9.7 | 9 (8.5) | |
Her2-neu Receptors | Â | Â | Â |
Positive (n=14) | 12.35 ± 5.8 | 13 (9.5) | =0.089** |
Negative (n=26) | 10.01 ± 8.9 | 7 (6.5) | |
Tumor grad | |||
GI (n=5) | 3.69±1.4 | 3.1(2.6) |  |
GII (n=18) | 9.43±6.11 | 6.85(11.08) | =0.002# |
GIII (n=15) | 15.03±9.20 | 11.11(13.4) |  |
Molecular subtype | Â | Â | Â |
Luminal A (n=10) | 5.88±4.9 | 4.18(5.06) | 0.007# |
Luminal B (n=19) | 10.93±5.55 | 8.4(9) | |
Her2neu over expression (n=4) | 8.03±5.24 | 7.98(9.13) | |
Triple negative (n=7) | 19.19±11.86 | 21.6(17.67) | |
Axillary LN State | |||
Positive (n=27) | 12.80 ± 8.6 | 10 (8.5) | = 0.016** |
Negative(n=13) | 6.73 ± 4.1 | 6.5 (6) |